Your browser doesn't support javascript.
loading
Anti-MDA5 Antibody-Positive Clinically Amyopathic Dermatomyositis Associated With Multiple Heterologous Carcinomas: A Case Report.
Nakano, Yoshio; Nishida, Koji; Okamoto, Norio; Gohma, Iwao; Yasuhara, Yumiko.
Afiliação
  • Nakano Y; Respiratory Medicine, Sakai City Medical Center, Osaka, JPN.
  • Nishida K; Respiratory Medicine, Sakai City Medical Center, Osaka, JPN.
  • Okamoto N; Respiratory Medicine, Sakai City Medical Center, Osaka, JPN.
  • Gohma I; Respiratory Medicine, Sakai City Medical Center, Osaka, JPN.
  • Yasuhara Y; Pathology, Sakai City Medical Center, Osaka, JPN.
Cureus ; 16(2): e54660, 2024 Feb.
Article em En | MEDLINE | ID: mdl-38523968
ABSTRACT
Dermatomyositis (DM), an autoimmune disorder, is linked to increased malignancy risk. A 53-year-old man with anti-melanoma differentiation-associated gene 5 (MDA5)-positive clinically amyopathic dermatomyositis (CADM) and rapidly progressing interstitial lung disease (RP-ILD) developed heterochronous gastric and colorectal cancers. Early endoscopic screenings led to successful curative resections, preventing recurrence. Despite low cancer incidence assumptions in patients with anti-MDA5-positive RP-ILD, this case advocates for reevaluation and periodic cancer screenings to enhance management, considering the improved survival with intensive therapy. Vigilance for multiple carcinomas at various time points is vital in CADM management.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article